Circulating metabolomic signatures of ultra-processed and minimally processed food intake and risk of cardiovascular disease and type 2 diabetes: 20-year follow-up in the Whitehall II cohort

BMC Medicine · Published 2026-07-21 · DOI 10.1186/s12916-026-05081-7

Free full text

Authors (6)

Mengmei E. Wang, Annie Britton, Michail Katsoulis, Kiara Chang, Eszter P. Vamos, Clare H. Llewellyn

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, M., Britton, A., Katsoulis, M., et al. (2026). Circulating metabolomic signatures of ultra-processed and minimally processed food intake and risk of cardiovascular disease and type 2 diabetes: 20-year follow-up in the Whitehall II cohort. BMC Medicine. https://doi.org/10.1186/s12916-026-05081-7

Related articles

• A Delphi consensus recommendations from China for the management of radiation-induced hearing loss in patients with nasopharyngeal carcinoma · BMC Medicine · 2026 · Same journal
• Defining the optimal interferon-stimulated genes panel to reflect serum interferon-α levels in patients with systemic lupus erythematosus · BMC Medicine · 2026 · Same journal
• Optimal doses of cognitive digital therapeutics for pediatric patients with cognitive impairments: A retrospective study based on big data · BMC Medicine · 2026 · Same journal
• Reduced neural sensitivity to emotional faces and voices in preterm five-year-olds: a comparative study · BMC Medicine · 2026 · Same journal
• Trimester-specific associations of maternal vitamin D metabolic markers with risks of small vulnerable newborns: a prospective birth cohort study · BMC Medicine · 2026 · Same journal
• Multimodal analysis reveals asynchronous aging dynamics between endometriosis-associated ovarian cancer and endometriosis patients · BMC Medicine · 2026 · Same journal
• The tumour microenvironment influences long-term tamoxifen benefit in postmenopausal ER+/HER2− breast cancer patients: a secondary analysis of the randomised Stockholm Tamoxifen (STO-3) trial · BMC Medicine · 2026 · Same journal
• Integrated proteomics and machine learning reveal AHNAK as a discriminative biomarker of atrial fibrillation in heart failure · BMC Medicine · 2026 · Same journal
• Comparative validation and local adaptation of gastric cancer risk assessment models in a large multicenter endoscopic screening cohort in China · BMC Medicine · 2026 · Same journal
• Functional decline in the final years of life: A multicohort study · BMC Medicine · 2026 · Same journal